Trump endorses Oz in key Senate race

Source: Politico | April 9, 2022 | Holly Otterbein and Natalie Allison

The celebrity TV doctor aggressively pursued Trump’s backing in the Pennsylvania primary.

Dr. Mehmet Oz has won the race for Donald Trump’s coveted endorsement in Pennsylvania’s Senate GOP primary.

In a key contest in the battle for the Senate majority this fall, the former president announced Saturday that he is backing Oz, praising the celebrity television doctor in a statement as “Pro-Life, very strong on Crime, the Border, Election Fraud, our Great Military, and our Vets, Tax Cuts, and will always fight for and support our under-siege Second Amendment.”

POLITICO previously reported that he had been leaning toward Oz, according to three people familiar with Trump’s thinking, speaking on the condition of anonymity.

Trump recently met with both Oz and former hedge fund CEO David McCormick in Mar-a-Lago and talked with multiple people about the GOP primary.

McCormick and Oz, as well as their allies, had been locked in a battle for months over Trump’s nod. With his loyal base and unparalleled popularity among Republican voters, Trump’s decision to pick Oz could have a significant impact on the contest. But Oz’s success or failure at the polls will also be closely watched as a test of Trump’s own hold on the party ahead of the 2024 presidential election, particularly since some of his candidates have faced challenges this year.

In Pennsylvania, Trump initially endorsed Sean Parnell for the Senate seat before Parnell dropped out amid claims of abuse from his estranged wife.

The choice between Oz and McCormick was even more fraught for the former president because Trumpworld is divided over the two front-running candidates. Some of Trump’s allies have strong opinions on the primary in Pennsylvania, and he risks upsetting friends in choosing Oz, just as he would have had he backed McCormick.

……..

Viewing 5 posts - 1 through 5 (of 5 total)
Viewing 5 posts - 1 through 5 (of 5 total)

You must be logged in to reply to this topic.